These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 12878983

  • 1. Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts.
    Khan E, Abu-Amer Y.
    J Lab Clin Med; 2003 Jul; 142(1):29-34. PubMed ID: 12878983
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ, Park KS, Chung SY, Sheen YY, Moon DC, Song YS, Kim KS, Song S, Yun YP, Lee MK, Oh KW, Yoon DY, Hong JT.
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [Abstract] [Full Text] [Related]

  • 3. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 4. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
    Butler R, Mitchell SH, Tindall DJ, Young CY.
    Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 6. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG.
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [Abstract] [Full Text] [Related]

  • 7. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
    Park KS, Lee RD, Kang SK, Han SY, Park KL, Yang KH, Song YS, Park HJ, Lee YM, Yun YP, Oh KW, Kim DJ, Yun YW, Hwang SJ, Lee SE, Hong JT.
    Exp Cell Res; 2004 Jul 15; 297(2):424-33. PubMed ID: 15212945
    [Abstract] [Full Text] [Related]

  • 8. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.
    Life Sci; 2009 Jul 03; 85(1-2):46-53. PubMed ID: 19409914
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.
    Clin Exp Pharmacol Physiol; 2008 Jan 03; 35(1):72-7. PubMed ID: 18047631
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation.
    Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL.
    J Bone Miner Res; 1999 Sep 03; 14(9):1522-35. PubMed ID: 10469280
    [Abstract] [Full Text] [Related]

  • 11. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul 03; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 12. Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells.
    Laurora S, Pizzimenti S, Briatore F, Fraioli A, Maggio M, Reffo P, Ferretti C, Dianzani MU, Barrera G.
    J Pharmacol Exp Ther; 2003 Jun 03; 305(3):932-42. PubMed ID: 12649303
    [Abstract] [Full Text] [Related]

  • 13. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS, Kwon CH, Park JY, Kim JH, Woo JS, Jung JS, Kim YK.
    Toxicol Appl Pharmacol; 2006 Nov 01; 216(3):426-35. PubMed ID: 16890972
    [Abstract] [Full Text] [Related]

  • 14. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
    Id Boufker H, Lagneaux L, Fayyad-Kazan H, Badran B, Najar M, Wiedig M, Ghanem G, Laurent G, Body JJ, Journé F.
    Bone; 2011 Dec 01; 49(6):1219-31. PubMed ID: 21893226
    [Abstract] [Full Text] [Related]

  • 15. Baicalein stimulates osteoblast differentiation via coordinating activation of MAP kinases and transcription factors.
    Kim JM, Lee SU, Kim YS, Min YK, Kim SH.
    J Cell Biochem; 2008 Aug 01; 104(5):1906-17. PubMed ID: 18384125
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep 01; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.
    Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL.
    J Cell Biochem; 1999 Sep 01; 74(3):357-71. PubMed ID: 10412038
    [Abstract] [Full Text] [Related]

  • 19. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells.
    Weber SM, Scarim AL, Corbett JA.
    Am J Physiol Endocrinol Metab; 2004 Mar 01; 286(3):E329-36. PubMed ID: 14600076
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling.
    Mix KS, Coon CI, Rosen ED, Suh N, Sporn MB, Brinckerhoff CE.
    Mol Pharmacol; 2004 Feb 01; 65(2):309-18. PubMed ID: 14742672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.